Literature DB >> 22661283

Concomitant aortic valve and ascending aorta replacement with moderate hypothermic circulatory arrest to treat an aortic bicuspid valve with post-stenotic dilatation.

Mitsumasa Hata1, Kenji Akiyama, Shinji Wakui, Ayako Takasaka, Motomi Shiono.   

Abstract

We recommend concomitant surgery for aortic valve replacement (AVR) and ascending aortic replacement using moderate hypothermic circulatory arrest (CA) for post-stenotic dilatation complicated by an aortic bicuspid valve. Cardiopulmonary bypass (CPB) was established from the right atrium to the dilated ascending aorta. As soon as the rectal temperature decreased to 28 °C, CA was commenced and the open distal anastomosis of a polyester prosthesis, without any cerebral perfusion, was completed. AVR was then carried out during rapid re-warming with CPB using a side arm of the prosthesis. This procedure exhibited safe and satisfactory results. There are many benefits of carrying out the procedure in this way; it avoids the requirement for cannulation to a calcified aortic arch, provides a good operative field, for an easier distal anastomosis and suturing at the valve site, and reduces the risk of further dilatation or dissection of the residual ascending aorta in the later phase.

Entities:  

Mesh:

Year:  2012        PMID: 22661283     DOI: 10.1007/s00595-012-0217-6

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  17 in total

1.  Reduction aortoplasty for dilatation of the ascending aorta in patients with bicuspid aortic valve.

Authors:  Matthias Bauer; Miralem Pasic; Raymond Schaffarzyk; Henryk Siniawski; Friedrich Knollmann; Rudolf Meyer; Roland Hetzer
Journal:  Ann Thorac Surg       Date:  2002-03       Impact factor: 4.330

2.  SUCCESSFUL REPLACEMENT OF THE ENTIRE ASCENDING AORTA AND AORTIC VALVE.

Authors:  M W WHEAT; J R WILSON; T D BARTLEY
Journal:  JAMA       Date:  1964-05-25       Impact factor: 56.272

3.  Dealing with dilated ascending aorta during aortic valve replacement: advantages of conservative surgical approach.

Authors:  T Carrel; L von Segesser; R Jenni; A Gallino; L Egloff; E Bauer; A Laske; M Turina
Journal:  Eur J Cardiothorac Surg       Date:  1991       Impact factor: 4.191

4.  Total arch replacement and open stent graft implantation using a newly developed stent graft: report of a case.

Authors:  Akira Sezai; Kenji Akiyama; Mitsumasa Hata; Tetsuya Niino; Isamu Yoshitake; Shinji Wakui; Kishu Fujita; Ayako Takasaka; Hideomi Kawachi; Tomohiko Murakami; Kazutomo Minami
Journal:  Surg Today       Date:  2011-03-02       Impact factor: 2.549

5.  Aortic root replacement with the pulmonary autograft: an invariably competent aortic valve?

Authors:  K M Dossche; A B de la Riviére; W J Morshuis; M A Schepens; S M Ernst; J J van den Brand
Journal:  Ann Thorac Surg       Date:  1999-10       Impact factor: 4.330

6.  Technical options in repairing the diseased ascending aorta with aortic valve involvement.

Authors:  J G Selle; F Robicsek; H K Daugherty; J W Cook; P J Hess
Journal:  Ann Thorac Surg       Date:  1981-12       Impact factor: 4.330

7.  Reduction aortoplasty for the ascending aortic aneurysm with aortic valve disease. Does bicuspid valve matter?

Authors:  Ho Young Hwang; Mi-Suk Shim; Eun-Ah Park; Hyuk Ahn
Journal:  Circ J       Date:  2010-12-09       Impact factor: 2.993

8.  Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease?

Authors:  Michael A Borger; Mark Preston; Joan Ivanov; Paul W M Fedak; Piroze Davierwala; Susan Armstrong; Tirone E David
Journal:  J Thorac Cardiovasc Surg       Date:  2004-11       Impact factor: 5.209

9.  Tailoring aortoplasty for repair of fusiform ascending aortic aneurysms.

Authors:  M G Barnett; A C Fiore; K J Vaca; T W Milligan; H B Barner
Journal:  Ann Thorac Surg       Date:  1995-02       Impact factor: 4.330

10.  Dissecting aortic aneurysm associated with congenital bicuspid aortic valve.

Authors:  W D Edwards; D S Leaf; J E Edwards
Journal:  Circulation       Date:  1978-05       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.